Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Acute Interstitial Pneumonitis”

20 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 20 results

Testing effectiveness (Phase 2)Study completedNCT04308681
What this trial is testing

A Study Measuring the Effectiveness, Safety, and Tolerability of BMS-986278 in Participants With Lung Fibrosis

Who this might be right for
Pulmonary Fibrosis
Bristol-Myers Squibb 403
Early research (Phase 1)Study completedNCT00563212
What this trial is testing

A Pilot Study of Aerosol Interferon-gamma for Treatment of Idiopathic Pulmonary Fibrosis

Who this might be right for
Pulmonary Fibrosis
NYU Langone Health 12
Large-scale testing (Phase 3)Ended earlyNCT00302341
What this trial is testing

DB289 Versus TMP-SMX for the Treatment of Acute Pneumocystis Jiroveci Pneumonia (PCP)

Who this might be right for
Pneumonia, Interstitial Plasma CellPneumocystis Carinii PneumoniaPneumonia, Pneumocystis Carinii+1 more
Immtech Pharmaceuticals, Inc 48
Not applicableUnknownNCT00518310
What this trial is testing

Azathioprine and Prednisone in the Treatment of Idiopathic Pulmonary Fibrosis

Who this might be right for
Idiopathic Pulmonary Fibrosis
Thorax National Institute 100
Large-scale testing (Phase 3)Study completedNCT00070590
What this trial is testing

Efficacy and Safety of Oral Bosentan in Pulmonary Fibrosis Associated With Scleroderma

Who this might be right for
Pulmonary FibrosisScleroderma, Systemic
Actelion 132
Not applicableStudy completedNCT05146934
What this trial is testing

The Relationship Between Hormone Sensitivity and Imaging of Idiopathic Interstitial Pneumonia by Artificial Intelligence

Who this might be right for
Idiopathic Interstitial Pneumonia
Peking University Third Hospital 150
Not applicableActive Not RecruitingNCT02951416
What this trial is testing

Clinical Course of Interstitial Lung Diseases: European IPF Registry and Biobank

Who this might be right for
Idiopathic Pulmonary FibrosisIdiopathic Interstitial PneumoniaInterstitial Lung Diseases+1 more
Andreas Guenther 2,000
Not applicableStudy completedNCT03836417
What this trial is testing

Molecular Diagnosis of Idiopathic Interstitial Pneumonias: a Prospective Study

Who this might be right for
Idiopathic Interstitial PneumoniaIdiopathic Pulmonary FibrosisNonspecific Interstitial Pneumonia
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's 55
Large-scale testing (Phase 3)Ended earlyNCT03955146
What this trial is testing

Zephyrus I: Evaluation of Efficacy and Safety of Pamrevlumab in Participants With Idiopathic Pulmonary Fibrosis (IPF)

Who this might be right for
Idiopathic Pulmonary Fibrosis
Kyntra Bio 393
Not applicableLooking for participantsNCT06036719
What this trial is testing

Interstitial Lung Disease: A Study From Infancy to Elderly Including Relatives

Who this might be right for
Interstitial Lung Diseases
Institut National de la Santé Et de la Recherche Médicale, France 3,000
Testing effectiveness (Phase 2)Study completedNCT01890265
What this trial is testing

Evaluate the Safety and Efficacy of FG-3019 (Pamrevlumab) in Participants With Idiopathic Pulmonary Fibrosis (IPF)

Who this might be right for
Idiopathic Pulmonary Fibrosis
Kyntra Bio 160
Not applicableStudy completedNCT02921828
What this trial is testing

A Safety and Efficacy of Pomalyst® Capsules Under the Actual Use in All Patients Who Are Treated With Pomalyst at a Dose of 1 mg, 2 mg, 3 mg, or 4 mg

Who this might be right for
Multiple Myeloma
Celgene 1,149
Very early researchStudy completedNCT03109873
What this trial is testing

Metformin Hydrochloride in Affecting Cytokines and Exosomes in Patients With Head and Neck Cancer

Who this might be right for
LarynxLipOral Cavity+1 more
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University 9
Not applicableUnknownNCT01088217
What this trial is testing

Role of Genetics in Idiopathic Pulmonary Fibrosis (IPF)

Who this might be right for
Idiopathic Pulmonary FibrosisFamilial Pulmonary FibrosisIdiopathic Interstitial Pneumonia+1 more
National Jewish Health 8,000
Not applicableStudy completedNCT01110694
What this trial is testing

Prospective Observation of Fibrosis in the Lung Clinical Endpoints Study

Who this might be right for
Idiopathic Pulmonary FibrosisIdiopathic Non-specific Interstitial Pneumonitis
Royal Brompton & Harefield NHS Foundation Trust 230
Not applicableActive Not RecruitingNCT03041623
What this trial is testing

Japanese Idiopathic Interstitial Pneumonias Registry

Who this might be right for
Idiopathic Interstitial Pneumonia
North East Japan Study Group 867
Not applicableUnknownNCT04179058
What this trial is testing

Interstitial Pneumonia With Autoimmune Features: Evaluation of Connective Tissue Disease Incidence During Follow-up

Who this might be right for
Idiopathic Interstitial Pneumonia
Central Hospital, Nancy, France 300
Large-scale testing (Phase 3)Ended earlyNCT04419558
What this trial is testing

Zephyrus II: Efficacy and Safety Study of Pamrevlumab in Participants With Idiopathic Pulmonary Fibrosis (IPF)

Who this might be right for
Idiopathic Pulmonary Fibrosis
Kyntra Bio 372
Testing effectiveness (Phase 2)Study completedNCT02036970
What this trial is testing

Bardoxolone Methyl Evaluation in Patients With Pulmonary Hypertension (PH) - LARIAT

Who this might be right for
Pulmonary Arterial HypertensionPulmonary HypertensionInterstitial Lung Disease+9 more
Biogen 166
Testing effectiveness (Phase 2)Study completedNCT02594839
What this trial is testing

Safety and Efficacy of Allogeneic Mesenchymal Stem Cells in Patients With Rapidly Progressive Interstitial Lung Disease

Who this might be right for
Idiopathic Interstitial PneumoniaInterstitial Lung DiseaseIdiopathic Pulmonary Fibrosis
Federal Research Clinical Center of Federal Medical & Biological Agency, Russia 20